Department of Medicine

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

Written by The New England Journal of Medicine | August 18, 2022

Co-authored by Jacinda Nicklas, MD, MPH, associate professor of medicine – Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.